BSE Live
Oct 17, 16:01Prev. Close
3157.55
Open Price
3159.55
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 17, 15:52Prev. Close
3156.70
Open Price
3157.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3108.10 (11)
Profit & Loss account of Dr Lal PathLabs (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 2,461.22 | 2,226.50 | 2,016.64 | 2,087.28 | 1,581.18 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Revenue From Operations [Net] | 2,461.22 | 2,226.50 | 2,016.64 | 2,087.28 | 1,581.18 | |
Total Operating Revenues | 2,461.40 | 2,226.64 | 2,016.88 | 2,087.41 | 1,581.27 | |
Other Income | 93.43 | 69.17 | 41.72 | 52.55 | 51.33 | |
Total Revenue | 2,554.83 | 2,295.81 | 2,058.60 | 2,139.95 | 1,632.60 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Purchase Of Stock-In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Operating And Direct Expenses | 481.46 | 451.42 | 447.15 | 502.25 | 397.26 | |
Changes In Inventories Of FGWIP And Stock In Trade | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Employee Benefit Expenses | 482.36 | 424.57 | 376.52 | 364.94 | 273.70 | |
Finance Costs | 22.31 | 29.36 | 37.53 | 30.18 | 16.00 | |
Depreciation And Amortisation Expenses | 141.92 | 143.60 | 150.19 | 108.11 | 77.20 | |
Other Expenses | 801.98 | 741.41 | 703.37 | 659.50 | 474.03 | |
Total Expenses | 1,930.03 | 1,790.36 | 1,714.77 | 1,664.97 | 1,238.19 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 624.80 | 505.45 | 343.83 | 474.98 | 394.41 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Profit/Loss Before Tax | 624.80 | 505.45 | 343.83 | 474.98 | 394.41 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 172.04 | 148.03 | 107.89 | 129.52 | 102.11 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | -39.49 | -4.87 | -5.14 | -1.79 | -4.18 | |
Other Direct Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Tax Expenses | 132.55 | 143.16 | 102.75 | 124.69 | 97.93 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 492.25 | 362.29 | 241.08 | 350.29 | 296.48 | |
Profit/Loss From Continuing Operations | 492.25 | 362.29 | 241.08 | 350.29 | 296.48 | |
Profit/Loss For The Period | 492.25 | 362.29 | 241.08 | 350.29 | 296.48 | |
Minority Interest | -5.11 | -4.56 | -2.23 | -5.46 | -4.86 | |
Consolidated Profit/Loss After MI And Associates | 487.14 | 357.74 | 238.85 | 344.83 | 291.62 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 58.00 | 43.00 | 29.00 | 42.00 | 35.00 | |
Diluted EPS (Rs.) | 58.00 | 43.00 | 29.00 | 42.00 | 35.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 199.91 | 199.48 | 99.43 | 115.71 | 99.11 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
22.07.2025
23.06.2025
Dr Lal PathLabs, Metropolis, others fall up to 2% as Amazon launches home diagnostics services
01.08.2025
Dr Lal PathLab Consolidated June 2025 Net Sales at Rs 669.80 crore, up 11.28% Y-o-Y
31.07.2025
Dr Lal PathLab Standalone June 2025 Net Sales at Rs 640.70 crore, up 19.87% Y-o-Y
25.04.2025
Dr Lal PathLab Standalone March 2025 Net Sales at Rs 577.20 crore, up 20.5% Y-o-Y
25.04.2025
Dr Lal PathLab Consolidated March 2025 Net Sales at Rs 602.60 crore, up 10.49% Y-o-Y
06.10.2021
Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
18.01.2021
Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
11.10.2019
Dr Lal Pathlabs Q2 PAT seen up 48.8% YoY to Rs. 84.8 cr: Kotak
15.07.2019
Dr Lal Pathlabs Q1 PAT seen up 17.6% YoY to Rs. 58.1 cr: Kotak